DOCSLIB.ORG

Oral Cancer Chairside Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Oral Cancer Chairside Guide Chairside Oral Cancer guide for Prevention and patient management Up to 70% of oral cancers are preceded by premalignant oral lesions, such as persistent red or white patches in the mouth. This chairside guide focuses on the most common sites of oral cancer: the tongue, the insides of the cheeks, and the floor of the mouth. TOBACCO FACTS ORAL CANCERTobacco F AuseCTS Types of tobacco use Effects of tobacco on oral health Smoking Smokeless Increases risk of: Facts about oral 800cancer million men smoke. Risk factors Profile of those at highest risk 200 million women smoke. • oral cancer cigarettes snu, dry 600,000 individuals die eac50%h yMAINear from Cigarette RISK smoking andFACTORS ismoist the most • smoker’s palateA typical high-risk profile for oral cancer OTHER RISK FACTORS TOTBheACCO ave rFageACTS 5-secondhandyear surv smoke:ival 156,000 men, commonbidis form of tobacco use, • periodontal diseaseis a man, over age 40, who uses tobacco 281,000 women and 166,000 children. Tobaccorate of use patients with oral Types of tobacco usebut all forms of tobaccoEffects of tobaccoare on oral health and/or is a heavy user of alcoholOral. TOBACCO FACTS At least 300 million people useTobacco Alcohol• premature tooth loss Environmental, infectious, cancer is about 50%. Smoking kreteksSmokeless chewing 800 million mensmokeless smoke. tobacco and 90% of these are linked with increasedIncreases risk risk of of: is HPV UV sun exposure Tobacco use Types of tobacco use tobaccoEffects ofAll tobacco three on forms•or algingi healthvitis of alcohol cancer ORAL CANCER FACTS 200 millionin wSoutheastomen smoke. Asia. oral cancer: regular• or aluse cancer of and other factors 800 million men smoke. cigarettesSmoking pipessnu,Smokeless dry Increases (beer,risk of: spirits,• staining and wine) 10 600,000 individualsIn die 2011, eac hmanufacturers year from spent about pipes,and moist cigars, waterpipes• smoker’s, palateas However, the male–femaleamong ratio has the 95%200 millionUS$9.5 women smoke.billion on advertising snus• oral cancerhave been• halitosis associated (bad breath) Facts about oral cancer secondhandRisk factors smoke: 156,000 men, cigarettes Profilesnu, dry of those at highest risk dropped from 6 to 1 in 1950 Aboutcigarettes 95% and of smokeless all bidis tobacco. wellcigars as all forms of• periodontalsmokeless disease UV radiation 600,000281,000 w indiomenviduals and 166,000die each cyhildrenear from. and moist • smoker’withs palate oral cancer,• loss of tastealthough andto smell about 2 to 1 at present.most common 50% secondhand smoke:o r156,000alGo cancersvernments men, spendoccur less than tobacco (snus, cdissolvhewing• prematureable s tooth loss TOBACCO FACTS AtCigarette least 300 million smoking people is usethe most bidis A typical high-risk• profileperiodontalspirits for disease o randal cancer beer have a , but can • Poor oral hygiene 281,000 women and 166,000 children on. tobaccokreteks control wcaterpipeshewing The average 5-year survival smokeless tobaccoin and personsUS$1 90% billion of othesever are40 40 tobacco, etc.). • gingivitis cancers Tobacco use common form ofTypes tobacco of tobacco use, use is tobaccoEffectsa man of, tobaccoover age on or 40al health, whigherho uses associated tobacco risk. rate of patients with oral Atin least Southeast 300 Asia.millioneac peopleh year use. • premature tooth loss but all formsyears of tobacco of age. are kretekspipes and/orchewing is a heavy •user staining of alcohol. • Chronic candidiasis smokeless tobacco and 90Smoking% of these are Smokeless Increases risk of: • gingivitis largely be prevented cancer is about 50%. 800 million menIn smoke.2011, manufacturers spent about Alltobacco three forms of alcohol UVB rays UVA rays in linkedSoutheast with Asia. increasedFrom The Challenge risk ofof Oral Disease – Asmokeless call for global action by FDI World Dental• Federation.halitosis (bad breath) US$9.5 billion on advertising snus• oral cancer • staining 200 million women smoke. Maps and graphics © Myriadpipescigars snu,Editions dry 2015 (beer, spirits and wine) by reducing • Herpes virus infections Incigarettes o2011,ral cancer:manufacturers and smokeless regular cigarettesspent tobacco. about use of • loss of taste and smell 600,000 individuals die each year fromThe average age and moist ha•v esmoker’ beens palateassociated• halitosis with (bad breath) US$9.5Governments billion spend on lessadv ertisingthan snusdissolvables secondhand smoke: 156,000pipes, men cigars,, waterpipes, as cigars However, the male–female ratio has exposure to risk 95% cigarettesUS$1 billion and smokeless onat tobacco thebidis tobacco. time control of diagnosiswaterpipes or•al periodontalcancer, althoughdisease• loss of taste and smell • Immunosuppressive 281,000 women and 166,000well aschildren all forms. of smokeless dropped from 6 to 1 in 1950 About 95% of all Goeacvernmentsh year60. spendis lessabout than 60. spiritsdissolvable ands beer have a factors At least 300 million people use waterpipes • premature tooth loss oral cancers occur US$1tobacco billion (snus, on tobacco ckretekshewing control chewing to about 2 to 1 at present. 1950 2015 conditions (HIV…) smokeless tobacco and 90% of these are higher associated risk. Fromeactobacco,h The year Challenge. etc.). of Oral Disease – A call for globaltobacco action by FDI World Dental• gingiFederation.vitis in persons over 40in Southeast40 Asia. Maps and graphics © Myriad Editions 2015 years of age. pipes • staining In 2011, manufacturersFromFrom spent The TheChallenge about Challenge of Oral Disease of Oral – A call Disease for global – action A call by FDIfor World global Dental action Federation. by FDI World Dental Federation. US$9.5 billion onMaps adAllv andertising three graphics forms© Myriad of Editions alcohol 2015 snus • halitosis (bad breath) Maps and graphics cigars© Myriad Editions 2015 cigarettes and smokeless(bee tobacco.r, spirits and wine) • loss of taste and smell The average age Governments spend less than dissolvables have been associatedwaterpipes with at the time of diagnosisUS$1 billion on tobacco control PATIENT MANAGEMENT each year. oral cancer, although 60 is about 60. spirits and beer have a From The Challenge of Oral Diseasehigher – A associated call for global action risk. by FDI World Dental Federation. 1950 2015 Maps and graphics © Myriad Editions 2015 BEFORE CANCER TREATMENT DURING CANCER TREATMENT AFTER CANCER TREATMENT From The Challenge of Oral Disease – A call for global action by FDI World Dental Federation. Maps and graphics © Myriad Editions 2015 Prepare patients Minimize the side effects of Monitor the healing process and before cancer treatment radiotherapy possible recurrence of oral cancer STEP 1 Eliminate oral infectious focus • Use local antiseptic, anaesthetic gel and • Follow-up and recall at least twice a year. STEP 2 Conduct non-invasive treatment non-alcoholic alkaline rinses in case of • Use antibiotic therapy in case post radiotherapy mucositis. STEP 3 Apply fluoride dental tray of traumatic dental procedures • Prevent caries by recommending brushing after radiotherapy. STEP 4 Recommend maxillofacial twice daily with a soft toothbrush and prosthesis if indicated • Conduct non-traumatic prosthetics for fluoride toothpaste between 2800ppm rehabilitation within 6 to 12 months. and 5000ppm and/or apply fluoride dental tray. • Recommend sugar-free chewing gum and salivary substitutes in case of xerostomia. Oral screening STEP 1 STEP 2 STEP 3 STEP 4 Oral health professionals are well-placed to Examine the Examine the Examine the floor Examine the screen high-risk patients for early signs of inner cheek lateral border of of the mouth palate oral cancer. Survival rates can be improved the tongue with early detection and timely referral to multi-disciplinary treatment centres. STEP 5 Diagnosis WHITE LESIONS UNIQUE ULCERATION It is recommended SCREENING BY PALPATION SCREENING BY PALPATION Ask patient if he/she is a smoker to use two mirrors and to palpate oral mucosa in all oral REMOVABLE TRAUMATIC INFECTION LESIONS APHTHOSIS NON-REMOVABLE screening steps (tuberculosis, HIV, syphilis, etc.) Eliminate all traumatic factors Biopsy and timely Local or systemic SWAB TEST Lichen planus, Tobacco Idiopathic pemphigus Leukoplakia Leukoplakia and conduct two week follow-up referral treatment Homogenous Non-homogenous (smooth and (thick, white with red spots, rugous) If no candidiosis, translucent) Biopsy to confirm if If candidiosis, consultation oral cell carcinoma and anti-fungal needed regarding timely referral treatment oral hygiene is needed (plaque bacteria) Stop tobacco Stop tobacco Biopsy: OIN, Dysplasia, SCC and regular follow-up (Squamous Cell Carcinoma) DISCLAIMER Please note that in this document ‘oral cancer’ refers to squamous cell carcinoma. NOTE Please consult national guidelines and recommendations on oral cancer management and prevention. FDI World Dental Federation This chairside guide was Avenue Louis-Casaï 51 • 1216 Genève • Switzerland www.fdiworlddental.org/oral-cancer made possible through an unrestricted grant from T +41 22 560 81 50 • [email protected] ©2018 FDI World Dental Federation.
Load more

Recommended publications
  • The Use of Biologic Agents in the Treatment of Oral Lesions Due to Pemphigus and Behçet's Disease: a Systematic Review
    Davis GE, Sarandev G, Vaughan AT, Al-Eryani K, Enciso R. The Use of Biologic Agents in the Treatment of Oral Lesions due to Pemphigus and Behçet’s Disease: A Systematic Review. J Anesthesiol & Pain Therapy. 2020;1(1):14-23 Systematic Review Open Access The Use of Biologic Agents in the Treatment of Oral Lesions due to Pemphigus and Behçet’s Disease: A Systematic Review Gerald E. Davis II1,2, George Sarandev1, Alexander T. Vaughan1, Kamal Al-Eryani3, Reyes Enciso4* 1Advanced graduate, Master of Science Program in Orofacial Pain and Oral Medicine, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA 2Assistant Dean of Academic Affairs, Assistant Professor, Restorative Dentistry, Meharry Medical College, School of Dentistry, Nashville, Tennessee, USA 3Assistant Professor of Clinical Dentistry, Division of Periodontology, Dental Hygiene & Diagnostic Sciences, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA 4Associate Professor (Instructional), Division of Dental Public Health and Pediatric Dentistry, Herman Ostrow School of Dentistry of USC, Los Angeles, California, USA Article Info Abstract Article Notes Background: Current treatments for pemphigus and Behçet’s disease, such Received: : March 11, 2019 as corticosteroids, have long-term serious adverse effects. Accepted: : April 29, 2020 Objective: The objective of this systematic review was to evaluate the *Correspondence: efficacy of biologic agents (biopharmaceuticals manufactured via a biological *Dr. Reyes Enciso, Associate Professor (Instructional), Division source) on the treatment of intraoral lesions associated with pemphigus and of Dental Public Health and Pediatric Dentistry, Herman Ostrow Behçet’s disease compared to glucocorticoids or placebo. School of Dentistry of USC, Los Angeles, California, USA; Email: [email protected].
    [Show full text]
  • Zeroing in on the Cause of Your Patient's Facial Pain
    Feras Ghazal, DDS; Mohammed Ahmad, Zeroing in on the cause MD; Hussein Elrawy, DDS; Tamer Said, MD Department of Oral Health of your patient's facial pain (Drs. Ghazal and Elrawy) and Department of Family Medicine/Geriatrics (Drs. Ahmad and Said), The overlapping characteristics of facial pain can make it MetroHealth Medical Center, Cleveland, Ohio difficult to pinpoint the cause. This article, with a handy at-a-glance table, can help. [email protected] The authors reported no potential conflict of interest relevant to this article. acial pain is a common complaint: Up to 22% of adults PracticE in the United States experience orofacial pain during recommendationS F any 6-month period.1 Yet this type of pain can be dif- › Advise patients who have a ficult to diagnose due to the many structures of the face and temporomandibular mouth, pain referral patterns, and insufficient diagnostic tools. disorder that in addition to Specifically, extraoral facial pain can be the result of tem- taking their medication as poromandibular disorders, neuropathic disorders, vascular prescribed, they should limit disorders, or atypical causes, whereas facial pain stemming activities that require moving their jaw, modify their diet, from inside the mouth can have a dental or nondental cause and minimize stress; they (FIGURE). Overlapping characteristics can make it difficult to may require physical therapy distinguish these disorders. To help you to better diagnose and and therapeutic exercises. C manage facial pain, we describe the most common causes and underlying pathological processes. › Consider prescribing a tricyclic antidepressant for patients with persistent idiopathic facial pain. C Extraoral facial pain Extraoral pain refers to the pain that occurs on the face out- 2-15 Strength of recommendation (SoR) side of the oral cavity.
    [Show full text]
  • Oral Manifestations of Systemic Disease Their Clinical Practice
    ARTICLE Oral manifestations of systemic disease ©corbac40/iStock/Getty Plus Images S. R. Porter,1 V. Mercadente2 and S. Fedele3 provide a succinct review of oral mucosal and salivary gland disorders that may arise as a consequence of systemic disease. While the majority of disorders of the mouth are centred upon the focus of therapy; and/or 3) the dominant cause of a lessening of the direct action of plaque, the oral tissues can be subject to change affected person’s quality of life. The oral features that an oral healthcare or damage as a consequence of disease that predominantly affects provider may witness will often be dependent upon the nature of other body systems. Such oral manifestations of systemic disease their clinical practice. For example, specialists of paediatric dentistry can be highly variable in both frequency and presentation. As and orthodontics are likely to encounter the oral features of patients lifespan increases and medical care becomes ever more complex with congenital disease while those specialties allied to disease of and effective it is likely that the numbers of individuals with adulthood may see manifestations of infectious, immunologically- oral manifestations of systemic disease will continue to rise. mediated or malignant disease. The present article aims to provide This article provides a succinct review of oral manifestations a succinct review of the oral manifestations of systemic disease of of systemic disease. It focuses upon oral mucosal and salivary patients likely to attend oral medicine services. The review will focus gland disorders that may arise as a consequence of systemic upon disorders affecting the oral mucosa and salivary glands – as disease.
    [Show full text]
  • Paraneoplastic Pemphigus with Clinical Features of Lichen Planus Associated with Low-Grade B Cell Lymphoma
    Report Paraneoplastic pemphigus with clinical features of lichen planus associated with low-grade B cell lymphoma Sónia Coelho, MD, José Pedro Reis, MD, Oscar Tellechea, MD, PhD, Américo Figueiredo, MD, PhD, and Martin Black, MD, PhD From the Department of Dermatology, Abstract University Hospital, Coimbra, Portugal, St Background Neoplasia-induced lichen planus is described as a cell-mediated reaction to John’s Institute of Dermatology, St Thomas’ unknown epithelial antigens. Paraneoplastic pemphigus (PNP), characterized by the presence Hospital, London, UK of a specific array of autoantibodies, probably represents a different form of presentation of the Correspondence same autoimmune syndrome where the mucocutaneous expression depends on the dominant Sónia Coelho pathologic mechanism. Clínica de Dermatologia, Hospital da Methods The authors report a case of PNP with predominant lichen planus-like lesions and Universidade review the relevant literature. We observed a 74-year-old female with vesico-bullous, erosive, P.3000–075 Coimbra target-shaped and flat papular lichenoid lesions on the lower legs, palms and soles, evolving for Portugal E-mail: [email protected] 3 weeks. Histopathology revealed a lichenoid dermatitis. Direct immunofluorescence showed C3 deposition around keratinocytes and epidermal IgG intranuclear deposition. Indirect immunofluorescence revealed circulating IgG with intercellular staining on rat bladder substrate. Immunoblotting demonstrated bands of 130, 190, 210 and 250 kDa antigens. A pararenal B cell lymphoma was found. Results Oral corticotherapy with 40 mg prednisolone daily was initiated with a good cutaneous response. Four months later, cyclophosphamide (50 mg/day) was introduced because of a discrete enlargement of the pararenal mass. The patient died on the seventh month of follow up as a result of respiratory insufficiency.
    [Show full text]
  • Cardiovascular Drugs-Induced Oral Toxicities: a Murky Area to Be Revisited and Illuminated
    Pharmacological Research 102 (2015) 81–89 Contents lists available at ScienceDirect Pharmacological Research j ournal homepage: www.elsevier.com/locate/yphrs Review Cardiovascular drugs-induced oral toxicities: A murky area to be revisited and illuminated a, b b Pitchai Balakumar ∗, Muthu Kavitha , Suresh Nanditha a Pharmacology Unit, Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Malaysia b Faculty of Dentistry, AIMST University, 08100 Bedong, Malaysia a r t i c l e i n f o a b s t r a c t Article history: Oral health is an imperative part of overall human health. Oral disorders are often unreported, but are Received 20 July 2015 highly troublesome to human health in a long-standing situation. A strong association exists between Received in revised form 22 August 2015 cardiovascular drugs and oral adverse effects. Indeed, several cardiovascular drugs employed clinically Accepted 8 September 2015 have been reported to cause oral adverse effects such as xerostomia, oral lichen planus, angioedema, Available online 25 September 2015 aphthae, dysgeusia, gingival enlargement, scalded mouth syndrome, cheilitis, glossitis and so forth. Oral complications might in turn worsen the cardiovascular disease condition as some reports suggest an Keywords: adverse correlation between periodontal oral disease pathogenesis and cardiovascular disease. These are Cardiovascular drugs certainly important to be understood for a better use of cardiovascular medicines and control of associated Oral adverse effects oral adverse effects. This review sheds lights on the oral adverse effects pertaining to the clinical use of Dry mouth Angioedema cardiovascular drugs. Above and beyond, an adverse correlation between oral disease and cardiovascular Dysgeusia disease has been discussed.
    [Show full text]
  • Pemphigus. S2 Guideline for Diagnosis and Treatment
    DOI: 10.1111/jdv.12772 JEADV GUIDELINES Pemphigus. S2 Guideline for diagnosis and treatment – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV) M. Hertl,1,* H. Jedlickova,2 S. Karpati,3 B. Marinovic,4 S. Uzun,5 S. Yayli,6 D. Mimouni,7 L. Borradori,8 C. Feliciani,9 D. Ioannides,10 P. Joly,11 C. Kowalewski,12 G. Zambruno,13 D. Zillikens,14 M.F. Jonkman15 1Department of Dermatology, Philipps-University Marburg, Marburg, Germany 2Department of Dermatology, Masaryk University, Brno, Czech Republic 3Department of Dermatology, Semmelweis University Budapest, Budapest, Hungary 4Department of Dermatology, School of Medicine University of Zagreb, Zagreb, Croatia 5Department of Dermatology, Akdeniz University, Antalya, Turkey 6Department of Dermatology, Karadeniz Technical University, Trabzon, Turkey 7Department of Dermatology, Tel-Aviv University, Tel-Aviv, Israel 8Department of Dermatology, University of Bern, Inselspital, Switzerland 9Department of Dermatology, University of Parma, Parma, Italy 10Department of Dermatology, Aristotle University of Thessaloniki, Thessaloniki, Greece 11Department of Dermatology, Rouen University Hospital, Rouen, France 12Department of Dermatology, Medical University of Warsaw, Warsaw, Poland 13Department of Dermatology, L’Istituto Dermopatico dell’Immacolata, Rome, Italy 14Department of Dermatology, University of Lubeck,€ Lubeck,€ Germany 15Department of Dermatology, University of Groningen, Groningen, The Netherlands *Correspondence: M. Hertl. E-mail: [email protected] Abstract Background Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blis- ters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal. Due to its rarity, only few prospective controlled therapeutic trials are available.
    [Show full text]
  • Oral Manifestations of Pemphigus Vulgaris
    Journal of Clinical & Experimental Dermatology Research - Open Access Research Article OPEN ACCESS Freely available online doi:10.4172/2155-9554.1000112 Oral Manifestations of Pemphigus Vulgaris: Clinical Presentation, Differential Diagnosis and Management Antonio Bascones-Martinez1*, Marta Munoz-Corcuera2, Cristina Bascones-Ilundain1 and German Esparza-Gómez1 1DDS, PhD, Medicine and Bucofacial Surgery Department, Dental School, Complutense University of Madrid, Spain 2DDS, PhD Student, Medicine and Bucofacial Surgery Department, Dental School, Complutense University of Madrid, Spain Abstract Pemphigus vulgaris is a chronic autoimmune mucocutaneous disease characterized by the formation of intraepithelial blisters. It results from an autoimmune process in which antibodies are produced against desmoglein 1 and desmoglein 3, normal components of the cell membrane of keratinocytes. The first manifestations of pemphigus vulgaris appear in the oral mucosa in the majority of patients, followed at a later date by cutaneous lesions. The diagnosis is based on clinical findings and laboratory analyses, and it is usually treated by the combined administration of corticosteroids and immunosuppressants. Detection of the oral lesions can result in an earlier diagnosis. We review the oral manifestations of pemphigus vulgaris as well as the differential diagnosis, treatment, and prognosis of oral lesions in this uncommon disease. Keywords: Pemphigus; Oral mucosa; Autoimmune bullous disease and have a molecular weight of 130 and 160 KDa, respectively [1,7,9,13]. The binding of antibodies to desmoglein at mucosal or Introduction cutaneous level gives rise to the loss of cell adhesion, with separation of epithelial layers (acantholysis) and the consequent appearance of Pemphigus vulgaris (PV) is the most frequently observed blisters on skin or mucosae [1,3].
    [Show full text]
  • Perianal White Sponge Nevus in a Hispanic Female: a Case Study N Busen, M Tompkins
    The Internet Journal of Advanced Nursing Practice ISPUB.COM Volume 4 Number 2 Perianal White Sponge Nevus In A Hispanic Female: A Case Study N Busen, M Tompkins Citation N Busen, M Tompkins. Perianal White Sponge Nevus In A Hispanic Female: A Case Study. The Internet Journal of Advanced Nursing Practice. 1999 Volume 4 Number 2. DOI: 10.5580/6c5 Abstract This article presents a case history of white sponge nevus (WSN) in the perianal area of a 23-year-old Hispanic female. WSN is a rare, autosomal dominant disorder that affects the noncornified stratified squamous epithelia. Clinically, the lesions are characterized by the presence of white, spongy plaques in the oral cavity. Extraoral lesions are found in other mucosal sites but are relatively uncommon in the absence of oral manifestations. Because WSN is rare, the differential diagnosis of this lesion may be difficult and the diagnosis is best made by a tissue biopsy performed in the context of a detailed patient and family history. The problems associated with differential diagnosis are addressed. INTRODUCTION was successfully treated for chlamydia in 1994 and has had Diagnosing lesions in the genital area by appearance can no other sexually transmitted diseases. She started sometimes prove elusive as illustrated by the case of a 23- menstruating at age 12 and became sexually active in her year-old Hispanic female who presented to an urban college late teens. She has been taking oral contraceptive pills health clinic with a long-standing complaint of a pruritic, (OCPs) intermittently for the past 5 years when sexually white lesion in the anogenital area.
    [Show full text]
  • World Journal of Clinical Cases
    World Journal of W J C C Clinical Cases Submit a Manuscript: http://www.wjgnet.com/esps/ World J Clin Cases 2014 December 16; 2(12): 866-872 Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx ISSN 2307-8960 (online) DOI: 10.12998/wjcc.v2.i12.866 © 2014 Baishideng Publishing Group Inc. All rights reserved. MINIREVIEWS Precancerous lesions of oral mucosa Gurkan Yardimci, Zekayi Kutlubay, Burhan Engin, Yalcin Tuzun Gurkan Yardimci, Department of Dermatology, Muş State Hos- alternatives such as corticosteroids, calcineurin inhibi- pital, 49100 Muş, Turkey tors, and retinoids are widely used. Zekayi Kutlubay, Burhan Engin, Yalcin Tuzun, Department of Dermatology, Cerrahpaşa Medical Faculty, Istanbul University, © 2014 Baishideng Publishing Group Inc. All rights reserved. 34098 Istanbul, Turkey Author contributions: Kutlubay Z designed research; Yardımci Key words: Oral premalignant lesions; Leukoplakia; G performed research; Tuzun Y contributed new reagents or ana- Erythroplakia; Submucous fibrosis; Lichen planus; Ma- lytic tools; Engin B analyzed data; Yardımci G wrote the paper. Correspondence to: Zekayi Kutlubay, MD, Department of lignant transformation Dermatology, Cerrahpaşa Medical Faculty, Istanbul University, Cerrah Paşa Mh., 34098 Istanbul, Core tip: Precancerous lesions of oral mucosa are the Turkey. [email protected] diseases that have malignant transformation risk at dif- Telephone: +90-212-4143120 Fax: +90-212-4147156 ferent ratios. Clinically, these diseases may sometimes Received: July 22, 2014 Revised: August 28, 2014 resemble each other. Thus, the diagnosis should be Accepted: September 23, 2014 confirmed by biopsy. In early stages, histopathological Published online: December 16, 2014 findings are distinctive, but if malignant transformation occurs, identical histological features with oral carci- noma are seen.
    [Show full text]
  • Transcription
    Amethyst: Welcome, everyone! This call is now being recorded. I would like to thank you for ​ being on the call this evening and to our Sponsors Genentech, Principia Biopharma, Argenx, and Cabaletta Bio for making today’s call possible. Today’s topic is Peer Support to answer your question about living with pemphigus and pemphigoid with the IPPF’s Peer Health Coaches. So before we begin, I want to take a quick poll to see how many of you have connected with an IPPF Peer Health Coach (either by phone or email)? While you are answering the poll let me introduce you to the IPPF Peer Health coaches: Marc Yale is the Executive Director of the IPPF and also works as a PHC. Marc was diagnosed ​ in 2007 with Cicatricial Pemphigoid, a rare autoimmune blistering skin disease. Like others with a rare disease, he experienced delays in diagnosis and difficulty finding a knowledgeable physician. Eventually, Marc lost his vision from the disease. This inspired him to help others with the disease. In 2008, he joined the IPPF as a Peer Health Coach. Becky Strong is the Outreach Director of the International Pemphigus & Pemphigoid ​ Foundation and also works as a PHC. She was diagnosed with pemphigus vulgaris in 2010 after a 17-month journey that included seeing six different doctors from various specialties. She continues to use this experience to shine a light on the average pemphigus and pemphigoid patient experience of delayed diagnosis and bring attention to how healthcare professionals can change the patient experience. Mei Ling Moore was diagnosed with Pemphigus Vulgaris in February of 2002.
    [Show full text]
  • Differential Diagnosis of Vesiculoerosive and Ulcerative Lesions
    Differential Diagnosis of Vesiculoerosive and Ulcerative Lesions Dr. Maria Fornatora Oral Pathology Differential Diagnosis of: VESICULOEROSIVE and ULCERATIVE LESIONS Created by Prashant Kaushik ISOLATED ACUTE CHRONIC TRAUMATIC ULCER SQUAMOUS CELL CARCINOMA RECURRENT APHTHOUS ULCER CHRONIC TRAUMATIC ULCER RECURRENT HSV LABIALIS DEEP FUNGAL INFECTION-oral manifestation RECURRENT HSV (INTRAORAL CROP) TUBERCULOSIS –oral manifestation NECROTIZING SIALOMETAPLASIA SYPHILIS (PRIMARY) MULTIPLE ACUTE CHRONIC PRIMARY HERPES SIMPLEX VIRUS EROSIVE LICHEN PLANUS MULTIPLE APHTHOUS ULCERS LICHENOID MUCOSITIS/Drug reaction VARICELLA ZOSTER VIRUS (Chickenpox & Shingles) BENIGN MUCOUS MEMBRANE PEMPHIGOID ALLERGIC REACTIONS LUPUS ERYTHEMATOSUS ERYTHEMA MULTIFORME PEMPHIGUS VULGARIS COXSACKIEVIRUS INFECTIONS (HERPANGINA, HAND-FOOT CHRONIC GRAFT VERSUS HOST DISEASE MOUTH DISEASE, etc) Differential Diagnosis for Isolated (single) Ulcerations • CC: “sore in my mouth” (symptomatic/painful ulcer- particularly true for acute ulcers) • Questions to ask the patient: –How long has it been present? – How quickly did it appear? (acute: duration <2 weeks; chronic>2weeks) Differential Diagnosis for Isolated (single) Ulcerations • Questions to ask the patient: – Is it getting better or worse? – Is s/he self medicating? If so with what? e.g. topical hydrogen peroxide or aspirin – Prior history of occurrence? If so, in same place intraorally or elsewhere? (both HSV and RAU have h/o recurrence) Differential Diagnosis for Isolated (single) Ulcerations • Questions to ask the patient: – Can the patient correlate a specific event or trigger with the onset? (e.g. smoking cessation associated with onset of RAU) – What are their symptoms? Pain? Paresthesia? (an ominous sign!), etc. – Was there a prodrome? Recurrent HSV and RAU have prodromes Differential Diagnosis for Isolated (single) Ulcerations • Examination hints: – Note color changes e.g.
    [Show full text]
  • Oral Verruciform Xanthoma and Erythroplakia Associated With
    Capocasale et al. BMC Res Notes (2017) 10:631 DOI 10.1186/s13104-017-2952-7 BMC Research Notes CASE REPORT Open Access Oral verruciform xanthoma and erythroplakia associated with chronic graft-versus-host disease: a rare case report and review of the literature Giorgia Capocasale1†, Vera Panzarella1†, Pietro Tozzo1†, Rodolfo Mauceri1†, Vito Rodolico2†, Dorina Lauritano3*† and Giuseppina Campisi1† Abstract Background: Oral verruciform xanthoma is an uncommon benign lesion. Although oral verruciform xanthoma occurs in healthy individuals, it has been also reported in association with some inflammatory conditions. The aim of this study is to report a case of oral verruciform xanthoma associated with chronic graft-versus-host disease and to review the literature on this topic. Case presentation: A 47-year-old Caucasian male presented to the Sector of Oral Medicine “V. Margiotta”, University Policlinic “P. Giaccone” of Palermo complaining of a mass on the gingiva. He first noticed the painless mass 1 year ago. He reported to have undergone allogenic hematopoietic stem cell transplantation 15 years ago for acute lympho- blastic leukaemia. Intraoral examination revealed a well-circumscribed, sessile yellowish and verrucous nodule upon canine, multiple yellowish and verrucous nodules on the hard palate, yellowish and verrucous nodules on left buccal mucosa. In addiction an area of white striae in a reticular pattern with erythema and ulceration was present on the dorsum of the tongue. This lesion was consistent with a known history of oral chronic graft versus host disease. Moreover, we observed a suspected area of oral erythroplakia yet on the dorsum of the tongue. In biopsy specimen of hard palate histopathological examination revealed a diagnosis of verrucous xanthoma of the oral cavity; in addiction in biopsy specimen of the dorsum of the tongue revealed the presence of erythroplakia with high grade dysplasia.
    [Show full text]